Stock listing
Ultragenyx Pharmaceutical Inc.
Selected listing: RARE · NASDAQ · USD · US
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Health Technology. Latest release Oct 2, 2026: Ultragenyx Announces Marketing Authorisation Application (MAA)…
- Ticker
- NASDAQ:RARE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. is a public company traded under the ticker RARE in the American market. Ultragenyx focuses on developing innovative treatments for rare and ultra-rare genetic diseases.
Latest news from Ultragenyx Pharmaceutical Inc.
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
October 1, 2026
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
October 2, 2026
Ultragenyx Announces Approval of FAYUVI Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A
September 18, 2026
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
September 17, 2026
Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome
September 2, 2026
Events
Research Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. company profile
View the public company page for Ultragenyx Pharmaceutical Inc. on 6ix.
Ultragenyx Pharmaceutical Inc. news
Read company news and market updates connected to Ultragenyx Pharmaceutical Inc..
Ultragenyx Pharmaceutical Inc. investor events
Find investor webinars, events, and replay context for Ultragenyx Pharmaceutical Inc..
Alternate listings
0LIF:LSE
GB · USD
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
UP0:GETTEX
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
RARE:BMV
MX · MXN
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
A1XCY0:LSX
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
A1XCY0:LS
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
R2AR34:BMFBOVESPA
BR · BRL
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
RARE:BIVA
MX · MXN
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
UP0:FWB
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
UP0:TRADEGATE
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
RARE:BOATS
US · USD
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
UP0:BX
CH · CHF
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.
UP0:DUS
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:NASDAQ.